iCardiac
AcquiredClario generates the richest clinical evidence
Philadelphia, United States · $4.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1001–5000
- Business Model
- B2B
- Website
- ert.com
- Total Funding
- $4.0M
- Last Round
- Venture RoundMar 2014
- Rounds
- 3
- Acquisition Date
- Dec 2017
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Advanced cardiac safety analysis technologies using ECG-based tools for clinical trials; acquired by ERT.
Summary
iCardiac is a Biotech company based in Philadelphia, United States. It has raised $4.0M in total across 3 rounds, most recently a Venture Round in Mar 2014. Investors include Norwest Venture Partners, ADvantage and Stonehenge Capital Company.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2017
Sign up to see all 4 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/icardiac"><img src="https://indexed.vc/api/badge/company/icardiac" alt="iCardiac on Indexed.vc" width="260" height="76" /></a>